DRUG · Mapped RxNorm record
Saxagliptin
Normalized identity: saxagliptinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes
NCT02315495
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Acarbose
Normalized identity: acarboseView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedCombining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
SaxagliptinDRUG · verified · RxNorm: saxagliptin
AcarboseDRUG · verified · RxNorm: acarbose
Sponsors & collaborators
Zilin Sunlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02315495 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.